Science Explorer Interactive view Map
Hospital / health system · Changzhou · China

Changzhou No.2 People's Hospital

In research, Changzhou No.2 People's Hospital stands highest in Life Sciences (#1,597 of 7,800 worldwide), Medicine (#2,884 of 10,443 worldwide) and Health Sciences (#3,787 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research — Cancer Research is 11.5× its share of world research.

czey.comROR OpenAlex
World rank, 2022–2025
#4,210
of 28,054 · #11,216 all time
Rank in China
#963
of 3,058
Research works
1.5k
▲ 152% vs 2013–17
Citations
16k
10.2 per fractional work
Top-10% rate
19.0%
record average 16.5%
Open access
57%
world 28%

What is Changzhou No.2 People's Hospital known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #1,597 of 7,800 18.1%199 #4433
MedicineField #2,884 of 10,443 18.9%363 #6889
Health SciencesDomain #3,787 of 11,982 19.3%377 #8848
Biochemistry, Genetics and Molecular BiologyField #1,932 of 3,579 17.0%141 #4830
Molecular BiologySubfield #1,595 of 2,175 18.5%82 #3537
Physical SciencesDomain #10,015 of 12,888 19.7%63 #17798

Each strip is that field’s whole ranked pool, with the notch where Changzhou No.2 People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#4,433 #1,597
  2. Medicine#6,889 #2,884
  3. Health Sciences#8,848 #3,787
  4. Biochemistry, Genetics and Molecular Biology#4,830 #1,932
  5. Molecular Biology#3,537 #1,595
  6. Physical Sciences#17,798 #10,015
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Changzhou No.2 People's Hospital specialise in?

Where its research is concentrated relative to its size: Cancer Research takes 11.5× the share of its output that it takes of world research.

  1. Cancer ResearchSubfield · 32.5 works12×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 6 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.06× its world share, 141 worksBiochemistry, Geneti…Immunology and Microbiology: 3.65× its world share, 24 worksImmunology and Micro…Neuroscience: 2.25× its world share, 24 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.14× its world share, 5 worksPharmacology, Toxico…Chemical Engineering: 0.22× its world share, 0 worksChemical EngineeringChemistry: 0.49× its world share, 5 worksChemistryComputer Science: 0.21× its world share, 11 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.12× its world share, 1 worksEnergyEngineering: 0.24× its world share, 23 worksEngineeringEnvironmental Science: 0.15× its world share, 5 worksEnvironmental ScienceMaterials Science: 0.64× its world share, 14 worksMaterials ScienceMathematics: 0.07× its world share, 0 worksMathematicsPhysics and Astronomy: 0.21× its world share, 3 worksPhysics and AstronomyDentistry: 0.70× its world share, 2 worksDentistryHealth Professions: 0.31× its world share, 5 worksHealth ProfessionsMedicine: 2.90× its world share, 363 worksMedicineNursing: 1.70× its world share, 5 worksNursingVeterinary: 0.54× its world share, 0 worksVeterinaryArts and Humanities: 0.01× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.01× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.16× its world share, 2 worksEconomics, Econometr…Psychology: 0.29× its world share, 6 worksPsychologySocial Sciences: 0.03× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.1×. Every wedge is a field page.

Who are the top researchers at Changzhou No.2 People's Hospital?

Ranked on the composite score, Qi Cao, Jianlin Wang and Xinye Ni lead among researchers whose main affiliation is Changzhou No.2 People's Hospital.

  1. 1 Qi Cao China · #610,030 worldwide 54 citations · 17 works
  2. 2 Jianlin Wang China · #1,196,058 worldwide 23 citations · 21 works
  3. 3 Xinye Ni China · #1,251,208 worldwide 40 citations · 26 works
  4. 4 Xiaoli Zhou China · #1,286,533 worldwide 12 citations · 27 works
  5. 5 Zhiqiang Sun China · #1,309,257 worldwide 17 citations · 20 works
  6. 6 Jingping Yu China · #1,382,432 worldwide 8 citations · 17 works
  7. 7 Ling Cen China · #1,504,289 worldwide 14 citations · 17 works
All ranked researchers at Changzhou No.2 People's Hospital

Which keywords describe research at Changzhou No.2 People's Hospital?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Oxidative Stress, Tumor Microenvironment, Epidemiology, Gene Expression, Biogenesis and Metastasis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer81▲ 9.3×50 topics
  2. Inflammation74▲ 5.4×78 topics
  3. Epidemiology52▲ 2.0×87 topics
  4. Oxidative Stress46▲ 4.3×54 topics
  5. Tumor Microenvironment30▲ 10×8 topics
  6. Gene Expression27▲ 6.9×14 topics
  7. Cardiovascular Disease26▲ 3.7×33 topics
  8. Metabolic Syndrome24▲ 4.6×22 topics
  9. Chemotherapy23▲ 5.0×21 topics
  10. Clinical Practice Guidelines22▲ 6.1×13 topics
  11. Regulation22▲ 6.2×9 topics
  12. Biomarkers21▲ 4.8×18 topics
  13. Biogenesis21▲ 18×3 topics
  14. Obesity20▲ 4.0×18 topics
  15. Metastasis20▲ 9.0×12 topics
  16. Epigenetic Regulation19▲ 14×6 topics
  17. Cell Death18▲ 12×6 topics
  18. Angiogenesis16▲ 7.6×15 topics
  19. Cancer Therapy16▲ 4.2×15 topics
  20. Cell Differentiation15▲ 25×2 topics
  21. RNA Regulation15▲ 22×2 topics
  22. Long Noncoding RNAs15▲ 27×1 topic
  23. Transcriptional Landscape15▲ 27×1 topic
  24. Diabetes14▲ 4.5×20 topics
  25. Immunity13▲ 5.1×9 topics
  26. Metabolism13▲ 4.0×24 topics
  27. Cancer Progression13▲ 11×8 topics
  28. Survival Analysis13▲ 7.1×6 topics
  29. Cancer Biomarkers12▲ 21×3 topics
  30. Lipid Peroxidation12▲ 17×2 topics
  31. Cardiovascular Risk12▲ 5.8×8 topics
  32. Ferroptosis12▲ 23×1 topic
  33. GPX412▲ 23×1 topic
  34. Disease11▲ 19×2 topics
  35. Endothelial Dysfunction11▲ 7.1×8 topics
  36. Gastric Cancer11▲ 14×3 topics
  37. Type 2 Diabetes11▲ 7.4×6 topics
  38. Translation10▲ 9.0×2 topics
  39. Therapeutics10▲ 14×2 topics
  40. Adjuvant Therapy10▲ 12×2 topics

Which research topics does Changzhou No.2 People's Hospital publish most on?

By volume in 2022–2025: Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis, MicroRNA in disease regulation and Circular RNAs in diseases.

Cancer-related molecular mechanisms research: 15 fractional worksFerroptosis and cancer prognosis: 12 fractional worksMicroRNA in disease regu…9MicroRNA in disease regulation: 9 fractional worksCircular RNAs in diseases9Circular RNAs in diseases: 9 fractional worksRNA modifications and cancer: 9 fractional worksGastric Cancer Management and Outcomes: 7 fractional worksCancer Immunotherapy and…6Cancer Immunotherapy and Biomarkers: 6 fractional worksImmune cells in cancer6Immune cells in cancer: 6 fractional worksPregnancy and preeclampsia studies: 5 fractional worksRadiomics and Machine Learning in Medical Imaging: 4 fractional works
Cancer ResearchPulmonary and Respiratory MedicineMolecular BiologyOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related molecular mechanisms research Cancer Research 15 works
  2. 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 12 works
  3. 3 MicroRNA in disease regulation Cancer Research 9 works
  4. 4 Circular RNAs in diseases Molecular Biology 9 works
  5. 5 RNA modifications and cancer Molecular Biology 9 works
  6. 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 7 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 6 works
  8. 8 Immune cells in cancer Immunology 6 works
  9. 9 Pregnancy and preeclampsia studies Obstetrics and Gynecology 5 works
  10. 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.2%not open42.8%

World: 28% of research is openly available.

with international co-authors7.1%domestic only92.9%

World: 19% is written across borders.

How has Changzhou No.2 People's Hospital's research output changed?

Output in 2018–2022 was 152% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Changzhou

All research institutions in Changzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.